Cigna Group (CI) director awarded 782 common shares in Form 4 filing

Rhea-AI Filing Summary

McClellan Mark B. reported acquisition or exercise transactions in this Form 4 filing.

Cigna Group director Mark B. McClellan received a grant of 782 shares of common stock. The award was recorded at a price of $0.0000 per share, reflecting stock-based compensation rather than a market purchase. Following this grant, he directly holds 6,891 Cigna common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider McClellan Mark B.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $.01 Par Value	782	$0.00	--

Holdings After Transaction: Common Stock, $.01 Par Value — 6,891 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 782 shares Grant price: $0.0000 per share Total holdings after grant: 6,891 shares +1 more

4 metrics

Shares granted 782 shares Stock award to director on April 22, 2026

Grant price $0.0000 per share Recorded value for 782-share stock grant

Total holdings after grant 6,891 shares Director’s direct Cigna common stock after transaction

Transaction type Grant, award, or other acquisition Form 4 transaction code A for common stock

Key Terms

Common Stock, $.01 Par Value, Grant, award, or other acquisition, Form 4

3 terms

Common Stock, $.01 Par Value financial

"security_title: Common Stock, $.01 Par Value"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4): { "issuerName": "Cigna Group""

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McClellan Mark B.

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	04/22/2026		A		782	A	$0	6,891	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

	Tyler Gratton, attorney-in-fact	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cigna Group (CI) disclose for Mark B. McClellan?

Cigna disclosed that director Mark B. McClellan received a grant of 782 shares of common stock. The shares were awarded at a stated price of $0.0000 per share, indicating a compensation-related stock grant rather than an open-market purchase or sale.

Was the Cigna (CI) insider transaction a stock purchase or a grant?

The transaction was a stock grant, categorized as a “Grant, award, or other acquisition.” McClellan received 782 common shares at a recorded price of $0.0000 per share, which is typical for equity awards provided as part of director compensation packages.

How many Cigna (CI) shares does Mark B. McClellan hold after this Form 4 transaction?

After receiving the 782-share grant, Mark B. McClellan directly holds a total of 6,891 Cigna common shares. This figure reflects his position immediately following the reported award and provides context for the size of the compensation-related grant.

What does the transaction code "A" mean in the Cigna (CI) Form 4 filing?

In this Form 4, transaction code “A” stands for “Grant, award, or other acquisition.” It indicates McClellan’s 782 Cigna common shares were acquired through a compensation-related stock award, not through an open-market purchase or sale of existing shares.

Does the Cigna (CI) Form 4 show any stock sales by Mark B. McClellan?

No stock sales are reported in this Form 4. The filing shows only one transaction: an acquisition of 782 shares via a grant. The transaction summary lists zero sell transactions, emphasizing the event is purely a compensation-related share award.